PCI BIOTECH HOLDING ASA (PCIB.OL) Stock Balance Sheet
OSL:PCIB - Euronext Oslo - NO0010405640 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 27.07M | 41.18M | 56.60M | 116.12M | 187.97M | |||
| Receivables | 3.84M | 2.57M | 6.16M | 12.20M | 13.16M | |||
| Other Current Assets | N/A | -1.00K | N/A | N/A | N/A | |||
| Total Current Assets | 30.91M | 43.75M | 62.76M | 128.32M | 201.13M | |||
| Non-Current Assets | ||||||||
| PPE Net | 310.00K | 297.00K | 723.00K | 7.66M | 7.99M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | 1.00K | N/A | 1.00K | |||
| Total Non-Current Assets | 310.00K | 297.00K | 724.00K | 7.66M | 7.99M | |||
| TOTAL ASSETS | 31.21M | 44.05M | 63.48M | 135.98M | 209.12M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 336.00K | 319.00K | 443.00K | 629.00K | 673.00K | |||
| Accrued Expenses | N/A | 3.07M | 3.37M | 14.22M | 11.88M | |||
| Accounts Payable | 1.72M | 712.00K | 495.00K | 3.75M | 5.19M | |||
| Other Current Liabilities | 5.70M | 872.00K | 1.44M | 2.32M | 2.11M | |||
| Total Current Liabilities | 7.76M | 4.97M | 5.75M | 20.91M | 19.85M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | N/A | 0.00 | 327.00K | 1.28M | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 33.00K | N/A | 0.00 | 32.00K | |||
| Total Non-Current Liabilities | 0.00 | 33.00K | 327.00K | 1.28M | 32.00K | |||
| TOTAL LIABILITIES | 7.76M | 5.01M | 6.08M | 22.19M | 19.88M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 22.33M | 0.00 | -54.58M | -448.65M | -373.20M | |||
| Additional Paid In Capital | N/A | 37.92M | 0.00 | 450.46M | 450.46M | |||
| Common Shares | 1.12M | 1.12M | 111.98M | 111.98M | 111.98M | |||
| Other Shareholders' Equity | 1.00K | 1.00K | 1.00K | -1.00K | N/A | |||
| Shares Outstanding | 37.33M | 37.33M | 37.33M | 37.33M | 37.33M | |||
| Tangible Book Value per Share | 0.63 | 1.05 | 1.54 | 3.05 | 5.07 | |||
| Total Shareholders' Equity | 23.45M | 39.04M | 57.40M | 113.79M | 189.24M | |||
| TOTAL LIABILITIES AND EQUITY | 31.21M | 44.05M | 63.48M | 135.98M | 209.12M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.01 | 0.01 | N/A | |||
| Current Ratio | 3.98 | 8.80 | 10.91 | 6.14 | 10.13 | |||
| Return On Assets (ROA) | -52.59% | -46.12% | -86.79% | -65.00% | -34.54% | |||
| Return On Equity (ROE) | -70.00% | -52.03% | -95.98% | -77.68% | -38.17% | |||
All data in NOK , ROIC based on taxRate of 0.23